Skip to content

A Randomized Controlled Trial to Evaluate the Efficacy of a PHR App for Self-Management Support and a Stapwise Reminder Interventions

A Randomized Controlled Trial Evaluating the Effectiveness of Stepwise Reminder Interventions Using a Self-Management-Supported PHR Application among Corporate Employees - STEP-UP trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1040260027
Enrollment
100
Registered
2026-05-13
Start date
2026-05-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Hypertension, Lifestyle-related disease, Metabolic syndrome

Interventions

If any of the following conditions are met, the HR representative will send a notification to the employee via internal email or personal email in a phased manner, recommending that they enter their d
D010548
PHR application, remind, support, monitoring

Sponsors

Dohi Kaoru
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged 18 or older 2) An employee of a participating research institution (including part-time and temporary staff) 3) Has high blood pressure or is classified as having hypertension (including those diagnosed by a medical institution within the past five years) 4) Owns a smartphone capable of connecting to the internet and installing this app 5) Is able to measure blood pressure at home

Exclusion criteria

Exclusion criteria: 1) Individuals who are unable to use a smartphone due to cognitive or physical impairment or disability 2) Individuals who have withdrawn their consent to install this app or to the Terms of Use and Consent Form 3) Individuals whom the principal investigator or a co-investigator deems unsuitable for inclusion in the study 4) Individuals who are participating in, or are scheduled to participate in, another clinical study that is likely to affect the treatment of their hypertension while participating in this study 5) Individuals with severe hypertension (equivalent to Stage III hypertension) or in a condition requiring urgent blood pressure reduction, where the principal investigator or occupational physician determines that participation in the study would be detrimental to the individual

Design outcomes

Primary

MeasureTime frame
Average change in systolic blood pressure at 12 weeks (office blood pressure and home blood pressure)

Contacts

Public ContactHiromasa Ito

Mie University Hospital

h-ito@med.mie-u.ac.jp+81-59-231-5015

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026